Public Profile

Exelead, Inc.

Exelead, Inc., a prominent player in the biopharmaceutical industry, is headquartered in the United States and operates across key regions globally. Founded in 2018, Exelead has quickly established itself as a leader in the development of innovative drug delivery systems and biologics, focusing on enhancing therapeutic efficacy and patient outcomes. The company’s core offerings include advanced lipid-based formulations and cutting-edge delivery technologies, which set them apart in a competitive market. With a commitment to quality and innovation, Exelead has achieved significant milestones, including strategic partnerships and successful product launches. Their dedication to research and development positions them as a trusted partner in the biopharmaceutical landscape, driving advancements in drug delivery solutions.

DitchCarbon Score

How does Exelead, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.

32

Industry Average

Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.

30

Industry Benchmark

Exelead, Inc.'s score of 32 is lower than 100% of the industry. This can give you a sense of how well the company is doing compared to its peers.

0%

Let us know if this data was useful to you

Exelead, Inc.'s reported carbon emissions

Exelead, Inc., headquartered in the US, currently does not have publicly available carbon emissions data or specific reduction targets. Without reported emissions figures, it is challenging to assess their carbon footprint or climate commitments. However, the absence of data may indicate a need for enhanced transparency in their environmental impact reporting. As the industry increasingly prioritises sustainability, Exelead's future climate initiatives and commitments will be crucial for aligning with global climate goals and demonstrating corporate responsibility.

Industry emissions intensity

Very low
Low
Medium
High
Very high
Some industries are more carbon intensive than others. Exelead, Inc.'s primary industry is Pharmaceutical Preparation Manufacturing, which is very low in terms of carbon intensity compared to other industries.

Location emissions intensity

Very low
Low
Medium
High
Very high
The carbon intensity of the energy grid powering a company's primary operations has a strong influence on its overall carbon footprint. This request for Exelead, Inc. is in US, which has a low grid carbon intensity relative to other regions.

Reduction initiatives & disclosure networks

Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.

Exelead, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.

Science Based Targets Initiative
Carbon Disclosure Project
The Climate Pledge
UN Global Compact
RE 100
Climate Action 100
Race To Net Zero
Reduction Actions

Where does DitchCarbon data come from?

Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers